|Articles|July 2, 2011

Pharmaceutical Technology

  • Pharmaceutical Technology-07-02-2011
  • Volume 35
  • Issue 7

Pharmaceutical Technology, July 2011 Issue (PDF)

Click the title above to open the Pharmaceutical Technology July 2011 issue in an interactive PDF format.

Articles in this issue

over 15 years ago

FDA Introduces Spectral Library

over 15 years ago

Biotech Financing Blues

over 15 years ago

All the Wrong Questions

over 15 years ago

In the Spotlight July 2011

over 15 years ago

Pharma Leads in Sustainability

over 15 years ago

In Search of an Optimal Solid Form

over 15 years ago

Report from Europe

Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.